HomeSmall Caps
Share

Huang's departure could weaken Nvidia. Who stands to benefit from orders placed with its competitors?

Aldiyar Anuarbekov

Aldiyar Anuarbekov

analyst
Any slowdown in the execution of Nvidias strategy will give its competitors an opportunity to close the gap, according to Omdia Chief Analyst Lian Je Su / Photo: Shutterstock.com

Any slowdown in the execution of Nvidia's strategy will give its competitors an opportunity to close the gap, according to Omdia Chief Analyst Lian Je Su / Photo: Shutterstock.com

Following Jensen Huang’s resignation on Thursday, November 12, Nvidia’s stock fell 4.3%, while shares of its competitors AMD and Broadcom rose more than 5%. Experts believe that if the leadership change slows down the release of new Nvidia chips, major customers may increase their purchases of AMD accelerators and invest more in their own development efforts. Oninvest analyst Aldiyar Anuarbekov examined which companies stand to benefit from this.

What Has Changed Since Huang's Departure

On November 12, Nvidia announced that its co-founder, Jensen Huang, had stepped down as CEO and president and resigned from the board of directors. Chief Financial Officer Colette Kress became interim CEO and retained her position as CFO. Nvidia shares opened 13.1% below the previous close, fell as much as 14.3% at their intraday low, but ended the session down 4.3%.

On the same day, William Blair upgraded its rating on AMD to “outperform” and downgraded its rating on Nvidia to “in line with the market.” Analysts believe that AMD could increase its share of the AI accelerator market through its Instinct lineup, and projects to develop custom chips could help it sell more server processors.

Armina Rosenberg, a managing director at Minotaur Capital, believes that the upcoming leadership change is unlikely to significantly affect procurement, according to Reuters. She noted that the chips Nvidia will ship over the next year or two have already been designed and are in production, and that customers’ spending plans for 2027 do not depend on who is leading the company. However, any slowdown in the execution of Nvidia’s strategy will give its competitors more opportunities to close the gap, believes Omdia Chief Analyst Lian Je Su.

Which companies stand to benefit?

If cloud companies and AI developers accelerate their work on alternatives to Nvidia, suppliers of chip design and testing technologies could also receive additional orders. Oninvest has identified three small companies that already have projects in this area: Cloud companies and chip developers are testing equipment from Cohu; a major supplier of AI accelerators has decided to purchase a test system from Aehr; and AMD has licensed Arteris’s technology for its next-generation chips.

Cohu (ticker symbol COHU)

Cohu, with a market capitalization of $2 billion, supplies semiconductor testing equipment: its Eclipse systems maintain the required temperature for high-performance processors during testing. In the third quarter of 2026, Cohu’s revenue grew 37% year-over-year to $173 million, and adjusted earnings per share were $0.43, compared with a loss of $0.06 a year earlier. The company attributes the growth in demand for Eclipse to the increasing complexity of chips, their rising power consumption, and stricter testing requirements.

Over the quarter, Cohu’s estimated potential annual sales in the high-performance computing segment rose by 18%, to approximately $1 billion. This figure includes projects at various stages, including those where the equipment is still undergoing testing by customers. Cohu expects to ship three times as many Eclipse systems in 2027 as it did in 2026. On November 10, the company announced that a fourth customer had confirmed the platform’s suitability for testing high-performance chips. The company is not disclosing the names, but they include major cloud providers and the chip developers that work with them, said Cohu CEO Louis Müller. One customer from the computing segment alone accounted for more than 10% of Cohu’s total quarterly revenue.

Following the quarterly earnings report, Jefferies maintained its “Buy” rating and raised its price target from $74 to $90. This is twice the closing price on November 13. Craig-Hallum also reaffirmed its “Buy” rating, raising its price target from $65 to $74. According to MarketWatch, the company has a total of eight “Buy” recommendations from analysts, with an average price target of $73.

Arteris (AIP)

Arteris licenses technologies that enable data exchange between chip blocks and chiplets, and receives licensing fees and royalties based on the number of chips produced. The company’s market capitalization is less than $1 billion. In August 2025, AMD licensed its FlexGen technology for the next generation of AI chips. In September 2026, when Arteris introduced an expanded lineup of solutions for multi-die chips, AMD’s senior director of chip design, Jason Miller, said that the partnership gives AMD early access to technology that simplifies the integration of chiplets.

In the third quarter of 2026, Arteris’ revenue grew 48% year-over-year to $25.8 million. The annual contract value, including royalties, reached $103.8 million, up 39% from a year earlier. One of the largest cloud providers and two companies ranked among the top ten in the semiconductor industry have expanded their use of Arteris technologies for developing chips and chiplets, including AI accelerators and data center processors. At the same time, Arteris’ net loss for the quarter rose from $9 million to $11.2 million. Another risk the company highlights in its annual report is that major developers may create similar technologies on their own.

On November 6, Oppenheimer reaffirmed its “Buy” rating, lowering its price target from $40 to $30. However, this still implies a 55% increase from the closing price on November 13. Earlier, TD Cowen also maintained its “Buy” recommendation but lowered its target price from $40 to $25, which is 30% above the most recent closing price. In total, the company’s stock has seven “Buy” ratings, with an average target price of $33.

Aehr Test Systems (AEHR)

Aehr, with a market capitalization of less than $2 billion, manufactures systems that test the reliability of chips under load and at high temperatures. In the first quarter of fiscal year 2027, which ended on September 25, 2026, its revenue tripled, from $11 million to a record $33 million. Net income was $7.2 million, compared with a loss of $2.1 million a year earlier. The company raised its full-year revenue forecast to $150 million, the upper end of its previous range of $130 million to $150 million.

The company announced that a major supplier of AI accelerators has decided to purchase a FOX-XP system for testing at its partner’s facility in Taiwan. Installation is scheduled for early 2027. The company expects a decision on using the system in mass production within a few months after installation and testing. Management estimates that for every 1 million accelerators produced annually, between five and ten systems may be required. Aehr estimates this to represent $35–70 million in potential revenue, taking consumable components into account. Meanwhile, in fiscal year 2026, Aehr’s five largest customers accounted for about 70% of its revenue, compared with 77% a year earlier.

On November 3, Jefferies maintained its “Buy” rating but lowered its price target from $175 to $140. This is approximately 145% above the stock’s most recent closing price. At the same time, Oppenheimer upgraded its rating to “Buy” and reaffirmed its price target of $120. In total, the company’s stock has seven “Buy” ratings from analysts, with an average price target of $120.8.

What Investors Should Keep an Eye On

If AMD increases sales of chips featuring Arteris technology, the supplier will be able to earn more royalties. Cohu and Aehr may receive additional orders if developers of alternative accelerators choose their equipment for mass-production testing. Cohu’s immediate milestone is the transition of customers to production testing on Eclipse, while Aehr’s is the customer’s decision regarding FOX-XP following testing in Taiwan.

Neil Shah, vice president of Counterpoint Research, suggests that following Huang’s departure, Nvidia may slow down its investments in its ecosystem and the conclusion of major infrastructure deals. The market’s next key event is Nvidia’s quarterly earnings report and earnings call with analysts, scheduled for November 17.

This is not intended as individual investment advice.

Share

Trending

Stock Screener
Buy
Sell
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Small Caps
Investment and Finance News